SRT StarTek, Inc. gains 17% Feb 1, 2018

StarTek, Inc. provides business process outsourcing services in the United States, Canada, Honduras, Jamaica, and the Philippines. It operates in three segments: Domestic, Nearshore, and Offshore. The company's service offerings include customer care, sales support, inbound sales, complex order processing, accounts receivable management, technical and product support, up-sell and cross-sell opportunities, customer intelligence analytics, and other industry-specific processes. It offers technical and product support services through telephone, e-mail, chat, facsimile, and the Internet; and sales support services comprising lead generation, direct sales, account management and retention programs, and marketing analysis and modeling. The company's provisioning and order processing services comprise full life cycle order management and technical sales support for high-end telecommunications services, such as wire-line, wireless, data, and customer premise equipment; order fallout from its clients' automated systems; and direct-to-consumer services, such as provisioning, order processing, and transfer of accounts between client service providers. Its receivables management services consist of first and third party collections services for clients in the telecommunication, cable and media, and healthcare industries; healthcare services include customer care, sales support, accounts receivable management, remote patient care, and medical triage to providers, payers, pharmaceutical, and medical devices; and industry-specific processes comprise training curriculum development, workforce management, customer analytics, quality monitoring services, and dispositions. The company was founded in 1987 and is headquartered in Greenwood Village, Colorado. http://www.priceseries.com/trade/SRT-StarTek-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018012320180201.html

SRNE Sorrento Therapeutics, Inc. gains 89% Feb 1, 2018

Sorrento Therapeutics, Inc., a clinical stage biotechnology company, primarily engages in the discovery and development of therapies focused on oncology and the treatment of chronic cancer pain worldwide. It develops therapeutic products for the treatment of auto-immune, inflammatory, neurodegenerative, and infectious diseases. The company offers resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for the treatment of intractable pain at end-stage disease. Its preclinical human therapeutic antibodies include antibody drug conjugates, bispecific approaches, and T-Cell Receptor, as well as Chimeric Antigen Receptor-T Cell (CAR-T) for adoptive cellular immunotherapy for the treatment of solid and liquid tumors. It is also involved in the development of T-007, an anti-CD38 CAR-T cellular therapy for the treatment of multiple myeloma, as well as for additional potential indications, such as amyloidosis and graft-versus-host disease; and T-009, an anti-CD123 CAR-T cellular therapy for the treatment of acute myelogenous leukemia. The company has license and collaboration agreement with Les Laboratoires Servier for the development, manufacture, and commercialization of products using its human immuno-oncology anti-PD-1 mAb STI-A1110. Sorrento Therapeutics, Inc. was founded in 2006 and is based in San Diego, California. http://www.priceseries.com/trade/SRNE-Sorrento-Therapeutics-Inc-stock-gains-89-percent-a-Trade-Record-by-priceSeries-2017122820180201.html

LGCY Legacy Reserves LP gains 37% Feb 1, 2018

Legacy Reserves LP acquires and develops oil and natural gas properties primarily in the Permian Basin, East Texas, Rocky Mountain, and Mid-Continent regions of the United States. As of December 31, 2016, the company owned interests in producing oil and natural gas properties in 627 fields comprising 10,775 gross productive wells, including 3,799 operated and 6,976 non-operated wells located in the Permian Basin, East Texas, Piceance Basin of Colorado, Texas Panhandle, Wyoming, North Dakota, Montana, Oklahoma, and other states. It had proved reserves of approximately 144.8 million barrels of crude oil equivalent. Legacy Reserves LP was founded in 2005 and is headquartered in Midland, Texas. http://www.priceseries.com/trade/LGCY-Legacy-Reserves-LP-stock-gains-37-percent-a-Trade-Record-by-priceSeries-2018010920180201.html

KEM Kemet Corporation gains 17% Feb 1, 2018

KEMET Corporation, together with its subsidiaries, manufactures and sells passive electronic components under the KEMET brand worldwide. The company operates through two segments, Solid Capacitors, and Film and Electrolytic. Its products include tantalum, multilayer ceramic, film, electrolytic, paper, and solid aluminum capacitors, as well as EMI filters. The company offers its capacitors for use in the automotive, communications, computer-related, industrial, consumer, military/aerospace, and alternative energy industries. KEMET Corporation sells its products to original equipment manufacturers, electronics manufacturing services providers, and electronics distributors. The company was founded in 1919 and is headquartered in Simpsonville, South Carolina. http://www.priceseries.com/trade/KEM-Kemet-Corporation-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2018010920180201.html

FCAU Fiat Chrysler Automobiles N.V. gains 28% Feb 1, 2018

N/A http://www.priceseries.com/trade/FCAU-Fiat-Chrysler-Automobiles-NV-stock-gains-28-percent-a-Trade-Record-by-priceSeries-2018010220180201.html

CRSP CRISPR Therapeutics AG gains 86% Feb 1, 2018

CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The CRISPR/Cas9 technology allows for changes to genomic DNA. The company has strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in other diseases. It operates in Switzerland, the United States, and the United Kingdom. CRISPR Therapeutics AG is headquartered in Basel, Switzerland. http://www.priceseries.com/trade/CRSP-CRISPR-Therapeutics-AG-stock-gains-86-percent-a-Trade-Record-by-priceSeries-2017122120180201.html

CLBS Caladrius Biosciences, Inc. gains 17% Feb 1, 2018

Caladrius Biosciences, Inc. provides development and manufacturing services to the cell therapy industry in the United States. The company offers process development and clinical manufacturing services for therapeutic candidates in various stages of development. It is also developing CLBS03, a T regulatory cell clinical Phase II therapy targeting adolescents with type 1 diabetes. Caladrius Biosciences, Inc. has a strategic collaboration with Hitachi Chemical Co. America, Ltd. and Hitachi Chemical Co., Ltd. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. Caladrius Biosciences, Inc. was founded in 1980 and is headquartered in Basking Ridge, New Jersey. http://www.priceseries.com/trade/CLBS-Caladrius-Biosciences-Inc-stock-gains-17-percent-a-Trade-Record-by-priceSeries-2017122820180201.html

CANF Can-Fite Biopharma Ltd gains 18% Feb 1, 2018

Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases, as well as sexual dysfunction. It offers CF101, which has completed Phase II/III clinical trials for the treatment of psoriasis; completed Phase II clinical trials for the treatment of rheumatoid arthritis; completed Phase I clinical study for the treatment of osteoarthritis; and completed Phase I study for the treatment of uveitis, as well as is in Phase II clinical trials for the treatment of glaucoma or related syndromes of ocular hypertension. The company also develops CF102 that conducts a Phase II study for treating hepatocellular carcinoma and hepatitis C virus; and CF602, which is in pre-clinical trial for the treatment of sexual dysfunction. Can-Fite BioPharma Ltd. was founded in 1994 and is headquartered in Petah-Tikva, Israel. http://www.priceseries.com/trade/CANF-Can-Fite-Biopharma-Ltd-stock-gains-18-percent-a-Trade-Record-by-priceSeries-2018012220180201.html

ABCD Cambium Learning Group, Inc. gains 15% Feb 1, 2018

Cambium Learning Group, Inc. operates as an educational solutions and services company in the United States and internationally. The company operates through three segments: Learning A-Z, Voyager Sopris Learning, and ExploreLearning. The Learning A-Z segment provides preK-6 education technology. It operates subscription-based Websites, such as Reading A-Z, Raz-Kids, Headsprout, Science A-Z, Writing A-Z, Vocabulary A-Z, and ReadyTest A-Z that offers online supplemental books, lessons, assessments, and other instructional resources for individual classrooms, schools, and districts. The Voyager Sopris Learning segment provides technology, materials, and professional development services for educators to ensure students graduate prepared for college, career, and satisfaction in life after K-12. It also offers Kurzweil 3000, a reading, writing, and learning software for addressing language and literacy difficulties; and Kurzweil 1000, a scan and read software that makes printed or electronic text accessible to people who are blind or visually impaired. The ExploreLearning segment develops STEM-based curriculum tools to demonstrate practical applicability of math and science fields. Its products include Gizmos, a library of online simulations of math and science concepts in grades 3-12; and Reflex, an adaptive online solution for math fact fluency development for grades 2-8. The company sells its products to public school districts, private and charter schools, teachers, home school and parent consumers, and other companies through sales force, and e-commerce and Internet. Cambium Learning Group, Inc. was incorporated in 2009 and is based in Dallas, Texas. http://www.priceseries.com/trade/ABCD-Cambium-Learning-Group-Inc-stock-gains-15-percent-a-Trade-Record-by-priceSeries-2018010520180201.html

ZBRA Zebra Technologies Corporation gains 16% Jan 31, 2018

Zebra Technologies Corporation, together with its subsidiaries, designs, manufactures, sells, and supports direct thermal and thermal transfer label printers, radio frequency identification (RFID) printer/encoders, dye sublimation card printers, real-time locating solutions, related accessories, and support software worldwide. Its products are primarily used in automatic identification, data collection, and personal identification applications. The company also provides mobile computing and advanced data capture technologies and services, which include rugged and enterprise-grade mobile computers; laser, imaging, and radio frequency identification based data capture products; wireless LAN solutions and software; and applications that are associated with these products and services. In addition, it offers barcode scanners; specialty printers for barcode labeling and personal identification; real-time location systems; and related accessories and supplies, such as self-adhesive labels and other consumables, utilities, and application software. Further, the company provides maintenance, repair, product support, system installation and integration services, and other services. It serves retail, transportation and logistics, manufacturing, healthcare, and other end markets. The company sells its products through a network of resellers, distributors, and end users representing industrial, service, and government organizations. Zebra Technologies Corporation was founded in 1969 and is headquartered in Lincolnshire, Illinois. http://www.priceseries.com/trade/ZBRA-Zebra-Technologies-Corporation-stock-gains-16-percent-a-Trade-Record-by-priceSeries-2018010320180131.html